C12N 2310/128
Processing or releasing ribozyme
Official title: processing or releasing ribozyme
C12N2310/128 (Processing or releasing ribozyme) appears on 23 US grants and 43 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 43
- Assignees
- 28
- Inventors
- 81
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 3 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 2 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 2 |
| 2020 | 1 | 4 |
| 2021 | 4 | 7 |
| 2022 | 4 | 9 |
| 2023 | 3 | 3 |
| 2024 | 2 | 3 |
| 2025 | 2 | 5 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- RNA molecules, methods of producing circular RNA, and treatment methods15 Sep 2026US 12,737,877 B2Cornell University
- CRISPR enzymes and systems2 Jun 2026US 12,644,111 B2Massachusetts Institute of Technology
- Ribosome variants for sequence defined polymer synthesis23 Sep 2025US 12,421,537 B2Northwestern University
- Compositions and methods to restore paternal UBE3A gene expression in human Angelman syndrome11 Feb 2025US 12,221,609 B2University of Connecticut
- Universal platform to enhance CRISPR-based gene editing for in vivo therapies3 Sep 2024US 12,077,771 B2Arizona Board of Regents on behalf of Arizona State University
- Ribozyme-activated rna constructs and uses thereof30 Apr 2026US 2026/0115275 A1The Regents of the University of California
- Ribozymes4 Dec 2025US 2025/0369036 A1Agency for Science, Technology and Research
- Archaeal pyrrolysyl trna synthetases for orthogonal use4 Sep 2025US 2025/0277249 A1
- Compositions and methods to restore paternal ube3a gene expression in human angelman syndrome1 May 2025US 2025/0136994 A1University of Connecticut
- Novel crispr enzymes and systems27 Mar 2025US 2025/0101400 A1Massachusetts Institute of Technology
Most cited
By later US patents
- Methods and compositions for directed genome editing19US 11,193,123 B2Rewrite Therapeutics, Inc. · 2021
- Simultaneous multiplex genome editing in yeast7US 10,815,467 B2Inscripta, Inc. · 2020
- Simultaneous multiplex genome editing in yeast6US 11,034,945 B2Inscripta, Inc. · 2021
- Methods and compositions for directed genome editing6US 11,352,623 B2Rewrite Therapeutics, Inc. · 2022
- Ribozyme with tRNA synthetase activity and methods of manufacturing and using the same4US 10,113,168 B2Purdue Reasearch Foundation · 2018